scispace - formally typeset
M

Maddalena Gigante

Researcher at University of Foggia

Publications -  44
Citations -  2593

Maddalena Gigante is an academic researcher from University of Foggia. The author has contributed to research in topics: Nephrin & Mutation. The author has an hindex of 22, co-authored 43 publications receiving 2164 citations. Previous affiliations of Maddalena Gigante include University of Bari & University of Turin.

Papers
More filters
Journal ArticleDOI

Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

Krzysztof Kiryluk, +91 more
- 01 Nov 2014 - 
TL;DR: A genome-wide association study of IgA nephropathy (IgAN), the most common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of European and East Asian ancestry is performed, suggesting a possible role for host–intestinal pathogen interactions in shaping the genetic landscape of IgAN.
Journal ArticleDOI

Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis

Krzysztof Kiryluk, +54 more
- 21 Jun 2012 - 
TL;DR: Variation at IgAN susceptibility loci correlates with differences in disease prevalence among world populations and inform genetic, biological, and epidemiological investigations of IgAN and permit cross-comparison with other complex traits that share genetic risk loci and geographic patterns with IgAN.

Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis

Krzysztof Kiryluk, +54 more
TL;DR: In this article, the authors localized five IgAN susceptibility loci on Chr.6p21 (HLA-DQB1/DRB1, PSMB9/TAP1, and DPA1/DPB2 loci), Chr.1q32 (CFHR3/R1 locus), and Chr.22q12 (HORMAD2 locus) and tested association of these loci in eight new independent cohorts of Asian, European, and African-American ancestry.
Journal ArticleDOI

Copy-Number Disorders Are a Common Cause of Congenital Kidney Malformations

TL;DR: The majority of the known CNV disorders detected in the RHD cohort have previous associations with developmental delay or neuropsychiatric diseases and should be considered in this population for the diagnosis of their specific genomic disorders and for the evaluation of the potential for developmental delay.